The Chairman & Chief Executive Officer of Green Thumb Industries is Exercising Options

By Carrie Williams

Today it was reported that the Chairman & Chief Executive Officer of Green Thumb Industries (GTBIFResearch Report), Benjamin Kovler, exercised options to sell 3,430 GTBIF shares for a total transaction value of $100.9K.

Following Benjamin Kovler’s last GTBIF Sell transaction on December 18, 2020, the stock climbed by 4.9%. In addition to Benjamin Kovler, 5 other GTBIF executives reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Green Thumb Industries’ latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $177 million and quarterly net profit of $22.46 million. In comparison, last year the company earned revenue of $75.8 million and had a GAAP net loss of $14.07 million. The company has a one-year high of $39.11 and a one-year low of $5.37. Currently, Green Thumb Industries has an average volume of 532.99K.

Based on 12 analyst ratings, the analyst consensus is Strong Buy with an average price target of $47.67, reflecting a -37.4% downside. One of the top 25 analysts, according to TipRanks.com, recently recommended Buy GTBIF with a $52.00 price target.

The insider sentiment on Green Thumb Industries has been negative according to 127 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 12 states and operates over 30 cannabis stores under the chains Rise and Essence. Green Thumb is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including Dr. Solomon’s, Dogwalkers, and Beboe.